Live Geos: https://partners.subjectwell.com/publishers/geos_report/887334fc-0bf2-46b8-98c8-8bc05442c427 Ages: 21+ Study Description: The purpose of this clinical study is to see how effective an investigational oral medication is at helping to treat symptoms associated with Progressive Pulmonary Fibrosis. You may be asked to attend 1 or more screening visits to determine if you are eligible to enroll in the study. If enrolled, you will receive either the oral medication being tested in this study or a placebo to be taken twice a day. The treatment period will last a minimum of 1 year and up to approximately 3 years and you will be asked to attend regular doctor’s visits. During these visits, you will complete various diagnostic tests, including a CT scan of your lungs, lung function tests, and blood sample collection for laboratory tests. The doctor’s office conducting the study will be able to provide you with more information about the study requirements. Qualifications: - Must already be diagnosed with Interstitial Lung Disease (ILD) or Progressive Pulmonary Fibrosis - Cannot be diagnosed with Idiopathic Pulmonary Fibrosis - Cannot have had a lung transplant - Cannot be diagnosed with Congestive Heart Failure

ClicksAdv, LLC